Potential antitumour and pro-oxidative effects of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate (QNACR)

References

• Bratt O, Häggman M, Ahlgren G, Nordle O, Björk A, Damber JE. Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer. Br J Cancer 2009;101:1233–1240.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen S, Lu X, Cheng H, Ou Y, Cheng H et al. Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors. Bioorg Med Chem Lett 2009;19:1851–1854.
   PubMedGoogle Scholar
• Chien CM, Yang SH, Lin KL, Chen YL, Chang LS, Lin SR. Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells. Chem Biol Interact 2008;176:40–47.
   PubMed Web of Science ®Google Scholar
• Mabeta P, Auer R, Mphahlele MJ. Evaluation of the antiangiogenic effects of 2-aryl-3-bromoquinolin-4(1H)-ones and a NCH3-4-oxo derivative. Biol Pharm Bull 2009;32:937–940.
   PubMedGoogle Scholar
• Horan TC, Zompa MA, Seto CT, Kim KK, Moore RG, Lange TS. Description of the cytotoxic effect of a novel drug Abietyl-Isothiocyanate on endometrial cancer cell lines. Invest New Drugs 2012;30:1460–1470.
   PubMedGoogle Scholar
• Li GX, Chen YK, Hou Z, Xiao H, Jin H, Lu G et al. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: A comparative study in vivo and in vitro. Carcinogenesis 2010;31:902–910.
   PubMed Web of Science ®Google Scholar
• Rodrigues JR, Charris J, Ferrer R, Gamboa N, Angel J, Nitzsche B et al. Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo. Invest New Drugs 2012;30:1426–1433.
   PubMedGoogle Scholar
• Rodrigues J, Abramjuk C, Vásquez L, Gamboa N, Domínguez J, Nitzsche B et al. New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer. Pharm Res 2011;28:907–919.
   PubMed Web of Science ®Google Scholar
• Rodrigues JR, Charris J, Camacho J, Barazarte A, Gamboa N, Antunes F. Cytotoxic effects of N’-formyl-2-(5-nitrothiophen-2-yl) benzothiazole-6-carbohydrazide in human breast tumor cells by induction of oxidative stress. Anticancer Res 2012;32:2721–2726.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Spooner RJ. (1983).Glutathione reductase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. Deerfield Beach, Florida: Verlag Chemie, 258–265.
   Google Scholar
• Rice KP, Penketh PG, Shyam K, Sartorelli AC. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Biochem Pharmacol 2005;69:1463–1472.
   PubMed Web of Science ®Google Scholar
• Tian WN, Pignatare JN, Stanton RC. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J Biol Chem 1994;269:14798–14805.
   PubMed Web of Science ®Google Scholar
• Bradford M. A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133–140.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004;7:97–110.
   PubMed Web of Science ®Google Scholar
• Zdolsek JM, Svensson I. Effect of reactive oxygen species on lysosomal membrane integrity. A study on a lysosomal fraction. Virchows Arch, B, Cell Pathol 1993;64:401–406.
   Google Scholar
• Crawford DR, Davies KJ. Adaptive response and oxidative stress. Environ Health Perspect 1994;102 Suppl 10:25–28.
   PubMedGoogle Scholar
• Chen T, Xu Y, Guo H, Liu Y, Hu P, Yang X et al. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: In vitro and in vivo anticancer activity and molecular mechanisms of action. PLoS ONE 2011;6:e20729.
   PubMedGoogle Scholar
• Yang C, Mwaikambo BR, Zhu T, Gagnon C, Lafleur J, Seshadri S et al. Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol Regul Integr Comp Physiol 2008;294:R467–R476.
   PubMed Web of Science ®Google Scholar